Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in France

France: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 96.0% in 2025. ▲ Rising

Latest (2025)
96.0%
Change on year
unchanged
World rank
27th
of 194 countries
All-time high
96.0%
in 2022
All-time low
0.0%
in 2008
Years of data
18
2008–2025

Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in France, 2008–2025

0204060801002008201620252008: 02009: 02010: 892011: 892012: 892013: 892014: 892015: 912016: 922017: 922018: 922019: 932020: 952021: 952022: 962023: 962024: 962025: 96

Source: World Health Organization, Global Health Observatory.

Analysis

France recorded 96.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in 2025. That is the highest value across all 18 years on record.

The figure is up 5.5% over ten years.

Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in France peaked at 96.0% in 2022 and was at its lowest, 0.0%, in 2008.

France ranks 27th of 194 countries on this measure, in the top quarter.

The long-run direction has been consistently rising across the 18 years of available data.

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.0% 0.0% 0.0% 2
2010s 90.5% 89.0% 93.0% 10
2020s 95.7% 95.0% 96.0% 6

Countries ranked near France

  1. 27 Eritrea 96.0% compare
  2. 27 Slovakia 96.0% compare
  3. 27 Denmark 96.0% compare
  4. 27 Armenia 96.0% compare
  5. 27 Mongolia 96.0% compare
  6. 27 Tunisia 96.0% compare
  7. 27 Japan 96.0% compare
  8. 27 Rwanda 96.0% compare
  9. 27 Qatar 96.0% compare
  10. 27 Nicaragua 96.0% compare

See the full ranking of 206 places →

More health data for France

All data for France →

Frequently asked questions

What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in France?
Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in France was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in France?
The highest recorded value was 96.0% in 2022.
What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in France?
The lowest recorded value was 0.0% in 2008.
How does France rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
France ranks 27th out of 194 countries with data for 2025.
Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in France?
Over the last ten years it is up 5.5%. The long-run trend across the full record is rising.
Where does this France data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed